All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: Carcinoma, Hepatocellular-21104161

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	21104161	A135C	PreS	S	Carcinoma, Hepatocellular	G S	View
2	21104161	A2962G	PreS	S	Carcinoma, Hepatocellular	G S	View
3	21104161	A3186G	PreS	S	Carcinoma, Hepatocellular	G S	View
4	21104161	A31T	PreS	S	Carcinoma, Hepatocellular	G S	View
5	21104161	A52C	PreS	S	Carcinoma, Hepatocellular	G S	View
6	21104161	A52T	PreS	S	Carcinoma, Hepatocellular	G S	View
7	21104161	C109A	PreS	S	Carcinoma, Hepatocellular	G S	View
8	21104161	C109T	PreS	S	Carcinoma, Hepatocellular	G S	View
9	21104161	C2931T	PreS	S	Carcinoma, Hepatocellular	G S	View
10	21104161	C2964A	PreS	S	Carcinoma, Hepatocellular	G S	View
11	21104161	C3026T	PreS	S	Carcinoma, Hepatocellular	G S	View
12	21104161	C3051T	PreS	S	Carcinoma, Hepatocellular	G S	View
13	21104161	C3063G	PreS	S	Carcinoma, Hepatocellular	G S	View
14	21104161	G105T	PreS	S	Carcinoma, Hepatocellular	G S	View
15	21104161	G2946A	PreS	S	Carcinoma, Hepatocellular	G S	View
16	21104161	T49A	PreS	S	Carcinoma, Hepatocellular	G S	View
17	21104161	T53C	PreS	S	Carcinoma, Hepatocellular	G S	View
18	21104161	A3054T	PreS	S	Carcinoma, Hepatocellular	G S	View
19	21104161	A3120T	PreS	S	Carcinoma, Hepatocellular	G S	View
20	21104161	C2875A	PreS	S	Carcinoma, Hepatocellular	G S	View
21	21104161	C3060T	PreS1	S	Carcinoma, Hepatocellular	G S	View
22	21104161	G2950A	PreS	S	Carcinoma, Hepatocellular	G S	View
23	21104161	G2951A	PreS	S	Carcinoma, Hepatocellular	G S	View
24	21104161	G3191C	PreS	S	Carcinoma, Hepatocellular	G S	View
25	21104161	T3066A	PreS	S	Carcinoma, Hepatocellular	G S	View
26	21104161	T3069G	PreS	S	Carcinoma, Hepatocellular	G S	View
27	21104161	C76A	PreS	S	Carcinoma, Hepatocellular	G S	View
28	21104161	A1C	PreS	S	Hepatitis B Virus Infection Carcinoma, Hepatocellular	G S	View
29	21104161	A3054C	PreS	S	Hepatitis B Virus Infection Carcinoma, Hepatocellular	G S	View
30	21104161	A3120C	PreS	S	Hepatitis B Virus Infection Carcinoma, Hepatocellular	G S	View
31	21104161	A31C	PreS	S	Hepatitis B Virus Infection Carcinoma, Hepatocellular	G S	View
32	21104161	C10A	PreS	S	Hepatitis B Virus Infection Carcinoma, Hepatocellular	G S	View
33	21104161	C2875T	PreS	S	Hepatitis B Virus Infection Carcinoma, Hepatocellular	G S	View
34	21104161	C3060A	PreS1	S	Hepatitis B Virus Infection Carcinoma, Hepatocellular	G S	View
35	21104161	C3116T	PreS1	S	Hepatitis B Virus Infection Carcinoma, Hepatocellular	G S	View
36	21104161	C76T	PreS	S	Hepatitis B Virus Infection Carcinoma, Hepatocellular	G S	View
37	21104161	C7A	PreS	S	Hepatitis B Virus Infection Carcinoma, Hepatocellular	G S	View
38	21104161	G105C	PreS	S	Hepatitis B Virus Infection Carcinoma, Hepatocellular	G S	View
39	21104161	G147C	PreS	S	Hepatitis B Virus Infection Carcinoma, Hepatocellular	G S	View
40	21104161	G2946C	PreS	S	Hepatitis B Virus Infection Carcinoma, Hepatocellular	G S	View
41	21104161	G3191A	PreS	S	Hepatitis B Virus Infection Carcinoma, Hepatocellular	G S	View
42	21104161	T3066C	PreS	S	Hepatitis B Virus Infection Carcinoma, Hepatocellular	G S	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.